A New Answer to Back Pain. A $1B Exit.
Lower back pain. One of the most common and most misunderstood conditions in medicine. A noisy market full of empty promises, exhausted patients, and clinicians skeptical of every cure.
Relievant Medsystems had something different.
The Challenge
Relievant had developed Intracept — a revolutionary procedure targeting vertebrogenic pain, a newly understood source of lower back pain. The science was rigorous. The clinical data was peer-reviewed and compelling. But their marketing was playing it safe — failing to unite the two most powerful things they had.
The Idea
Through Brand Anthropology, F&N Med uncovered a rare truth. On one side: years of clinical evidence. On the other: profound human stories. Patients who got their lives back. Physicians forever changed by what they’d witnessed.
Those two truths had never been united in one brand.
Living Proof.
A simple, profound declaration that tied outcomes to evidence — and gave the brand a soul as strong as its science.
The Work
Every tactic and touchpoint became further proof of the idea. Patient education materials gave suffering patients a voice. Physician tools gave clinical advocates the language to champion the procedure. Employee materials gave the internal team a rally cry at every turn.
One brand idea. Every stakeholder. Every channel.
The Result
A massive surge in awareness, adoption, and physician confidence. Every campaign KPI shattered.
And the ultimate proof of concept: Relievant Medsystems was acquired by Boston Scientific in a deal valued at over $1 billion.
When a brand reflects the lives it changes — and carries both proof and purpose — it has an undeniable way to maximize enterprise value.